Lunasin from Wheat Inhibits a Key Step in Cancer Gene Activation

What the researchers found

Lunasin isolated from wheat seeds at different developmental stages inhibited core histone H3 and H4 acetylation in a dose-dependent manner. This is significant because histone acetylation is an epigenetic switch that can activate cancer-promoting genes.

Key findings included:

- Wheat was confirmed as a new dietary source of lunasin (previously found only in soy and barley)

- The peptide's identity was confirmed by Western blot and LC-ESI-MS mass spectrometry

- Lunasin extracted from livers of rats fed lunasin-enriched wheat also inhibited histone acetylation, confirming the peptide survives digestion intact and bioactive

- The amount of lunasin correlated strongly with the degree of histone acetylation inhibition

Why it matters

Epigenetic changes — modifications to how genes are expressed without changing the DNA sequence — play a major role in cancer development. A naturally occurring food peptide that can block one of these cancer-promoting switches (histone acetylation) and survive digestion to reach internal organs is a compelling candidate for cancer chemoprevention through diet.

How the study worked

Researchers extracted lunasin from wheat seeds at different developmental stages and confirmed its identity using Western blot and liquid chromatography electrospray ionization mass spectrometry (LC-ESI-MS). They measured histone acetylation inhibition using a non-radioactive histone acetyltransferase assay. For the bioavailability component, male Sprague-Dawley rats were fed lunasin-enriched wheat, and lunasin was then extracted from their livers and tested for histone acetylation inhibitory activity.

What this study cannot tell us

This is a preclinical study using cell-free assays and a rat feeding model. No human data on lunasin's cancer-preventive effects exists. The histone acetylation inhibition was measured in vitro and in rat liver extracts — it's unclear whether the same effect occurs in human cells at dietary concentrations. The correlation between lunasin amount and acetylation inhibition, while strong, doesn't prove cancer prevention in whole organisms.

How to read the evidence

This is a preclinical laboratory study using cell-free assays and a rat model. While the mechanistic data is clear and well-controlled, the evidence is far from demonstrating cancer prevention in humans.

When this study was published

Published in 2007, this was an early study establishing wheat as a source of lunasin and confirming its oral bioavailability. Lunasin research has continued since, though human clinical data remains limited.

The bigger picture

Lunasin sits at the intersection of nutrition science, epigenetics, and cancer prevention. It's one of a small number of food-derived peptides with a defined molecular mechanism for cancer prevention — targeting histone acetylation. The finding that it's present in wheat (not just soy) broadens its potential dietary relevance, since wheat is consumed far more widely globally.

Questions still open

• Is the amount of lunasin in a normal wheat-containing diet sufficient to meaningfully inhibit histone acetylation in humans?
• Does lunasin's histone acetylation inhibition translate to reduced cancer risk in long-term human studies?
• Could lunasin-enriched wheat varieties be developed as a functional food for cancer chemoprevention?

Common questions

Read the original research

The cancer preventive peptide lunasin from wheat inhibits core histone acetylation.

Cancer letters, 255(1), 42-8

Citation

Jeong, Hyung Jin; Jeong, Jin Boo; Kim, Dae Seop; Park, Jae Ho; Lee, Jung Bok; Kweon, Dae-Hyuk; Chung, Gyu Young; Seo, Eul Won; de Lumen, Ben O. (2007). The cancer preventive peptide lunasin from wheat inhibits core histone acetylation.. Cancer letters, 255(1), 42-8.